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Introduction: Current guidelines for spontaneous intracerebral hemorrhage (ICH) recommend maintaining cerebral
perfusion pressure (CPP) between 50 and 70 mmHg, depending on the state of autoregulation. We continuously
assessed dynamic cerebral autoregulation and the possibility of determination of an optimal CPP (CPPopt) in ICH
patients. Associations between autoregulation, CPPopt and functional outcome were explored.
Methods: Intracranial pressure (ICP), mean arterial pressure (MAP) and CPP were continuously recorded in 55
patients, with 38 patients included in the analysis. The pressure reactivity index (PRx) was calculated as moving
correlation between MAP and ICP. CPPopt was defined as the CPP associated with the lowest PRx values. CPPopt was
calculated using hourly updated of 4 hour windows. The modified Rankin Scale (mRS) was assessed at 3 months and
associations between PRx, CPPopt and outcomes were explored using Pearson correlation and Fisher’s exact test.
Multivariate stepwise logistic regression models were calculated including standard outcome predictors along with
percentage of time with PRx >0.2 and percentage of time within the CPPopt range.
Results: An overall PRx indicating impairment of pressure reactivity was found in 47% of patients (n = 18). The mean
PRx and the time spent with a PRx > 0.2 significantly correlated with mRS at 3 months (r = 0.50, P = 0.002; r = 0.46,
P = 0.004). CPPopt was calculable during 57% of the monitoring time. The median CPP was 78 mmHg, the median
CPPopt 83 mmHg. Mortality was lowest in the group of patients with a CPP close to their CPPopt. However, for none
of the CPPopt variables a significant association to outcome was found. The percentage of time with impaired
autoregulation and hemorrhage volume were independent predictors for acceptable outcome (mRS 1 to 4) at three
months.
Conclusions: Failure of pressure reactivity seems common following severe ICH and is associated with
unfavorable outcome. Real-time assessment of CPPopt is feasible in ICH and might provide a tool for an
autoregulation-oriented CPP management. A larger trial is needed to explore if a CPPopt management results in
better functional outcomes.Introduction
The state of cerebral autoregulation is related to functional
outcome as has been shown in several studies including
ischemic stroke [1], spontaneous intracerebral hemorrhage
(ICH) [2,3], subarachnoid hemorrhage (SAH) [4] and trau-
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reproduction in any medium, provided the orindex (PRx), Czosnyka et al. have introduced a method
for continuous monitoring of cerebrovascular reactivity
which can be used at the bedside [6]. Of importance,
the PRx can be used to calculate the ‘optimal cerebral
perfusion pressure’ (CPPopt) which is defined as the
cerebral perfusion pressure (CPP) associated with the
lowest values of PRx [5]. Studies of traumatic brain injury
[5,7] and subarachnoid hemorrhage [8] have shown a
relationship between outcome and the difference between
the actual CPP and CPPopt. Just recently an algorithm
to continuously assess CPPopt in regularly updated
four-hour intervals has been published [7]. However,Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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on dynamic autoregulation [2,3,9,10] and CPP manage-
ment [11,12] and, so far, there are no data regarding
autoregulation-based CPP management. However, current
guidelines recommend maintaining CPP between 50
and 70 mmHg (Class IIb, Level C), depending on the state
of autoregulation [13,14], conceding that these recom-
mendations are entirely based on data from TBI patients.
Here, we (1) continuously assessed the state of cerebro-
vascular reactivity in patients with severe spontaneous ICH
treated on a Neurocritical Care Unit (NCCU) and (2) inves-
tigated if the CPPopt concept is applicable for ICH patients.
Furthermore, the association of impaired autoregulation
and CPPopt to functional outcome as reported for TBI [5]
and SAH [8] patients was exploratively investigated.Methods
Patients
Between 2007 and 2009, 55 non-consecutive patients with
spontaneous ICH admitted to the Heidelberg NCCU were
prospectively included in our monitoring database. Inclusion
criteria were: (1) spontaneous ICH and (2) the need for
intracranial pressure (ICP) measurement. Our clinical stand-
ard protocol includes ICP measurement for all ICH patients
who are analgosedated and mechanically ventilated. Further-
more, if patients have an indication for placement on an
extraventricular drainage due to intraventricular extension
of the hemorrhage, we usually aim to place a Raumedic
NEUROVENT (RAUMEDIC AG, 95233 Helmbrechts,
Germany) probe, allowing ICP measurement during simul-
taneous cerebrospinal fluid (CSF) drainage (see below). All
patients required intubation and mechanical ventilation
and were continuously sedated using midazolam, sufentanil,
ketamine and/or propofol. A total of 18 patients had been
included in a previous study [2]. Therapy was aimed to keep
ICP <20 mmHg and CPP >60 mmHg according to current
guidelines and local standards [13]. All patients were venti-
lated to achieve partial arterial oxygen pressures above
80 mmHg and a partial pressure of carbon dioxide in the
blood (PaCO2) of 30 to 40 mmHg. ICH severity and neuro-
logical deficit on admission were assessed by the National
Institutes of Health Stroke Scale (NIHSS). Hematoma
volume was calculated from the first computed tomography
(CT) scan using the axbxcx0.5 method [15]. The amount of
intraventricular blood was estimated using the Graeb score
[16]. The SAPS II (Simplified Acute Physiology Score II)
on admission was extracted from the hospital patient
database as a measure for overall disease severity. Out-
come at three months was assessed using the modified
Rankin Scale (mRS) based on a telephone interview or
evaluation of the reports from the rehabilitation clinic.
The study was part of a larger neuromonitoring project.
The retrospective analysis of the monitoring data wasapproved by the local ethics committee (Ethics Committee
University of Heidelberg, S-139/2007, Amendment IV).
For retrospective data analysis, the need for informed
consent was waived.
Neuromonitoring and data recording
Intracranial pressure was measured using a Raumedic NEU-
ROVENT probe, providing a combined probe allowing ICP
measurement during simultaneous CSF drainage. In six pa-
tients, ICP was measured by a standard external ventricular
drain (EVD). These patients were excluded from the current
analysis since ICP values are not correctly measured via an
open EVD. Blood pressurewasmeasured from the radial artery
(Dräger, Medical DeutschlandGmbH, Lübeck, Germany). ICP,
systolic and diastolic blood pressure, mean arterial pressure
(MAP), CPP and heart rate were synchronously recorded with
a sampling frequency of 1 Hz using a commercially available
software (ICU pilot, M Dialysis AB, Johanneshov, Sweden).
The datawere stored on a bedside computer.
Assessment of pressure reactivity index (PRx)
Data files were cleaned from epochs containing incom-
plete data recordings. Incomplete recordings were caused
by disturbed interaction between the monitoring system
and the recording software or by complete disconnection
of the patient from the monitoring system (for example,
in-house transportations). Next, data were re-sampled to
obtain one value every 10 seconds. Then, PRx was calcu-
lated as a moving linear (Pearson) correlation between 30
consecutive values (=five-minute time window) of MAP
and ICP as described by Aries et al. [7]. For calculation of
PRx only, data points fulfilling the criteria MAP between
50 and 120 mmHg, ICP >0 mmHg and CPP between 30
and 120 mmHg were included into the analysis, thereby
aiming to further eliminate artifacts and outlier values, for
example, due to flushing of the arterial system or shorter
disconnections of one probe. According to the literature, a
PRx >0.2 was defined as impaired cerebrovascular reactiv-
ity [6]. For each patient the time spent with a PRx >0.2
was calculated as the percentage of the total monitoring
time. Furthermore, PRx values were averaged using Fisher-
Z-Transformation to obtain an average value for each
patient. All calculations were performed using Matlab
(version R2007b, Mathworks, Ismaning, Germany).
Assessment of CPPopt
The optimal CPP (CPPopt) was calculated according to
the algorithm published by Aries et al. [7]. Shortly, all
recorded CPP values of each patient were divided into
bins of 5 mmHg and corresponding PRx values were
averaged using Fisher-Z-transformation within these
groups. Fisher-Z-transformation was used because of
the expected non-normal distribution of PRx values.
CPPopt in general is defined as the CPP value associated
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an example). For continuous calculation and update of
CPPopt values, the calculation was repeated every hour
using a four-hour moving time window. An automatic
algorithm to identify CPPopt was used as published by
Aries et al. [7]. Furthermore, the difference between
the real CPP and CPPopt was continuously calculated
within the four-hour moving time window. A median
value of the continuously calculated difference between
the actual CPP and CPPopt was recorded for each patient
and used for further analysis (Δ). The percentage of the
total monitoring time during which CPPopt was calculable
was recorded for each patient. In addition, the time each
patient spent within (CPPopt ± 5 mmHg), below (CPP <
CPPopt-5 mmHg) and above (CPP > CPPopt + 5 mmHg)
the continuously updated CPPopt was calculated as the
percentage of the total monitoring time. Finally, CPPoptFigure 1 Determination of CPPopt in two exemplary patients.
The pressure reactivity index (PRx) is plotted against cerebral perfusion
pressure (CPP). PRx values >0.2 indicate impaired pressure reactivity.
Patient (A) reaches the PRx minimum for CPP values around
103 mmHg (black star). The patient (B) has the optimal CPP around
87 mmHg (black star). Error bars indicate standard errors.was identified based on the entire monitoring data avail-
able for each patient as described by Steiner et al. [5].
Statistical data analysis
Spearman rank correlation was used in univariate ana-
lysis to assess the relationship among PRx, time spent
within, below and above the CPPopt range and outcome
at three months.
In addition, patients were grouped according to their
median difference between real CPP and CPPopt (three
groups: median Δ ±5 mmHg within CPPopt range, me-
dian Δ >5 mmHg above CPPopt and median Δ >5 mmHg
below CPPopt). The distribution of dichotomized out-
come parameters (mortality, acceptable (mRS 1 to 4) and
favorable (mRS 1 to 3) outcome) was compared using
Fisher’s exact test.
Finally, separate forward stepwise logistic regression
models were calculated to predict mortality, and favorable
and acceptable outcome at three months. A stepwise
model was chosen due to the explorative nature of the
analysis. Due to the limited number of patients, only the
known outcome predictors including age (years), initial
hemorrhage volume (ml), presence of intraventricular
blood in addition to percentage of time with PRx >0.2 and
percentage of time within the CPPopt range were included
in the model. To account for general disease severity in
this special subset of ICU patients, the SAPS II score
was also included in the model. There was no significant
correlation between the included covariates. Statistical
analysis was performed using the SPSS software package
(IBM Deutschland GmbH, Ehningen, Germany).
Results
Patients’ characteristics and outcomes
In total, 55 patients with spontaneous ICH were prospect-
ively monitored. Of these, four were excluded because of
monitoring time <12 hours or CPP below 30 mmHg, one
because of early withdrawal of care, one because of terminal
stage malignoma and one because of generalized brain
edema in a follow-upCCT. Additionally, the five patients with
purely intraventricular hemorrhage were excluded as well as
the patients who had standard EVDs without continuous ICP
monitoring. All patients in whom full therapeutic measures
initially were undertaken have been included in our analysis.
This left 38 patients for the current analysis.
During their ICU stay, in three patients it was decided
not to escalate therapeutic measures (days 7, 8, 17), two
of these died. The mean age was 58 years (±SD 16, range
18 to 84 years). Median NIHSS at admission was 30.5
(IQR 20, range 7 to 39). The median SAPS II on admis-
sion was 13 (IQR 5.3, range 6 to 32).
Median hematoma size was 36 ml (IQR 50, range 3 to
144 ml), 34 patients (89.5%) had intraventricular hemor-
rhage extension, the median Graeb score was 6.5 (IQR 5,
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hemorrhage, 5 (13.2%) lobar and 1 brainstem and cere-
bellar hemorrhage (2.6%). With respect to etiology, 23
patients (60.5%) had hypertensive hemorrhage, 4 had
hemorrhage associated with coagulopathy (10.5%), 5
had hemorrhage of other etiologies (13.2%) and for 6
patients no etiology could be determined (15.8%).
Median total monitoring time was 78 hours (IQR 74,
range 21 to 190 hours). A total of 12 (31.6%) patients
underwent hematoma evacuation, 2 (5.3%) had hemicra-
niectomy and 1 (2.6%) had hematoma evacuation and
hemicraniectomy (for this patient only data before surgery
were available).
At three months, 3 patients (8.1%) attained a mRS of
2, 7 patients (18.9%) a mRS of 3, 11 patients (29.7%) a
mRS of 4, 5 patients (13.5%) a mRS of 5. In-hospital
mortality was 23.7% (n = 9), mortality at three months
was 29.7% (n = 11). For one patient outcome at three
months was not available.
Analysis of cerebrovascular pressure reactivity
The mean PRx was suggestive for impaired pressure re-
activity defined as PRx >0.2 in 47.4% (n = 18) of patients.
The median time spent in PRx ranges >0.2 was 45.4% of
the total monitoring time (IQR 23.0, range 15.9 to 95.1).
The mean PRx and the time spent with a PRx >0.2
were significantly correlated to mRS at three months
(r = 0.50, P = 0.002 and r = 0.46, P = 0.004).
In our cohort, autoregulatory failure was not correlated
to ICH severity: neither the mean total PRx nor the mean
PRx on the first day of monitoring were significantly cor-
related to admission status assessed by NIHSS (r = −0.23,
P = 0.159 and r = -0.22, P = 0.181) or hemorrhage volume
(r = 0.14, P = 0.398 and r = 0.09, P = 0.605).
Analysis of optimal CPP (CPPopt)
Figure 1 shows two exemplary patients to depict the
CPPopt concept.
CPPopt was calculable during a median 57.1% of the
total monitoring time (IQR 27.3, range 0 to 92.9). In a
single patient, CPPopt was not calculable at all. The
median of all continuously calculated CPPopt values was
83 mmHg (IQR 10, range 68 to 98). The median of all
continuously calculated actual CPP values was 78 mmHg
(IQR 8, range 62 to 92). The median CPPopt based on the
CPP and PRx values of the entire monitoring time was
93 mmHg (IQR 12.5, range 68 to 113). The median
CPP of the entire monitoring time was 79 mmHg (IQR
9, range 61 to 92). Median ICP was 10 mmHg (IQR 3.5,
range 2 to 22).
Patients spent 10.5% of their total monitoring time
within the continuously updated CPPopt range (IQR
10.8, range 0 to 33%). The percentage of time above the
CPPopt range was 15% (IQR 13.1, range 0 to 64) and thetime spent below the CPPopt range was 26.7% (IQR
23.6, range 0 to 59) in the median. The continuously calcu-
lated difference between CPP continuous CPPopt (Δ)
was -5.6 mmHg (IQR 9.0, range -12.9 to 9.4) in the median.CPPopt and outcome
There was no linear correlation between mRS at three
months and the times spent within, above or below the
continuously updated CPPopt. Furthermore, functional
outcome was not correlated to total monitoring time
(r = -0.045, P = 0.791).
The correlation between median Δ and outcome was
not assessed since we did not assume a linear relationship.
Figure 2 instead depicts the relationship among mortality,
acceptable and favorable outcome, and the individual
median of the continuously calculated difference between
real CPP and CPPopt (mmHg). A total of 36 patients were
grouped according to their median Δ (n = 36 since for 1
patient outcome was not available, and in 1 patient
CPPopt was not determinable): 21 patients (55.3%)
lay 5 mmHg or more below their CPPopt values (me-
dian Δ -7.9 mmHg, range -5.5 to -12.9, IQR 4), 10 patients
(26.3%) lay ±5 mmHg within their individual CPPopt range
(median Δ -1.05 mmHg, range -4.9 to 4.3, IQR 5.6) and 6
patients (15.8%) were 5 mmHg or more above their CPPopt
range (median Δ 6.7 mmHg, range 5.2 to 9.4, IQR 2.7).
Mortality was lowest in the group of patients within the
CPPopt range (10%), while it was almost equal in those
more than 5 mmHg below (38.1%) or above (33.3%)
CPPopt (P = 0.241, Fisher’s exact test, Figure 2A).
The percentage of patients with acceptable outcome
was highest when CPP was within the CPPopt range
(70%), compared to 47.6% of those below and 50% of those
above CPPopt (P = 0.523, Fisher’s exact test, Figure 2B).
In contrast, patients who were more than 5 mmHg
above their CPPopt range had the highest percentage of
favorable outcome (33.3%), compared to 20% of patients
within the CPPopt range and 28.6% of those more than
5 mmHg below CPPopt (P = 0.769, Fisher’s exact test,
Figure 2C).
The distribution of the NIHSS scores or hemorrhage
volume did not differ significantly among the three groups
(P = 0.630 and P = 0.287, Kruskal-Wallis-test).Outcome prediction - multivariate models
Mortality at three months was predicted by age and ini-
tial hemorrhage volume (Table 1). The only significant
predictor of good outcome (mRS 1 to 3) at three months
was younger age. Independent predictors for acceptable
outcome at three months were lower percentage of time
with PRX >0.2 and lower hemorrhage volume. The vari-
able ‘time spent within the CPPopt range’ did not reach
significance in any of the models.
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Figure 2 Relationsship between CPPopt and outcomes. The
relationship between (A) mortality, (B) acceptable outcome and (C)
favorable outcome and the individual median difference between
continuous calculation of cerebral perfusion pressure (CPP) and
optimal CPP using overlapping hourly moving windows of 4 hour
duration (n = 36).
Table 1 Stepwise logistic regression models to predict
outcomes at three months
B (SE) OR 95% CI P
Mortality at three months1
Age 0.08 (0.04) 1.08 1.00 to 1.17 0.042
Hemorrhage volume 0.03 (0.01) 1.03 1.01 to 1.06 0.101
Good outcome at three months (mRs 1 to 3)2
Age -0.13 (0.04) 0.88 0.81 to 0.96 0.004
Acceptable outcome at three months (mRS 1 to 4)3
% time PRx >0.2 -0.06 (0.03) 0.94 0.90 to 1.00 0.038
Hemorrhage volume −0.02(0.1) 0.98 0.96 to 1.00 0.054
Included variables: age [years], hemorrhage volume [ml], presence of
intraventricular hemorrhage, percentage of time with PRx >0.2, percentage of
time within the CPPopt range, SAPS II score (1Nagelkerkes R2 0.47, 2Nagelkerkes
R2 0.50, 3Nagelkerkes R2 0.38), B, regression coefficient; CI, confidence interval;
OR, odds ratio; SE, standard error.
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To our knowledge, this series is the largest available on
dynamic assessment of cerebral autoregulation in severeICH patients. Furthermore, it is the first study assessing
the concept of an autoregulation-oriented CPP manage-
ment in ICH. We have found that impairment of pressure
reactivity occurs in almost half of the cases following
spontaneous ICH. The PRx and the time spent with a
PRx >0.2 were significantly correlated to mRS at three
months. The amount of time a patient had impaired
pressure reactivity (PRx >0.2) was an independent pre-
dictor for acceptable outcome at three months. These
results confirm the findings of a previous pilot study [2].
Importantly, the CPPopt concept seems applicable in
ICH patients. In our retrospective, explorative analysis,
calculation of CPPopt was feasible in all but one patient
and during 57% of the monitoring time. This number is
almost identical to the number indicated by Aries et al.
who reported that identification of CPPopt was on average
feasible during 55% of the recording period in their cohort
of 326 TBI patients [7]. The median CPPopt value was
83 mmHg and thereby higher than the threshold or
70 mmHg recommended in current guidelines [13,14].
This is potentially interesting since a recent study by
Ko et al. applying microdialysis and brain tissue oxy-
genation study in 18 ICH patients showed that CPP
values between 50 and 70 mmHg were associated with
brain tissue hypoxia, depicting the possibly detrimental
effects of hypoperfusion [11]. In our series, however, we
did not find a significant relationship between functional
outcome at three months and any of the CPPopt variables.
Aries et al. have found in their much larger TBI cohort
that hypoperfusion was associated with mortality while
hyperperfusion was correlated with severe disability. In
contrast, in our cohort of ICH patients, both hypo- as well
as hyperperfusion seemed harmful as could be concluded
from the mortality rates in the different CPP groups. Mor-
tality was lowest for patients close to their individual
CPPopt. At the same time, patients in this group had the
highest percentage of acceptable outcome. These findings,
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results for favorable outcome remain inconclusive. In our
cohort, the highest percentage of patients with favorable
outcome was in the group of those with 5 mmHg or more
above their individual CPPopt while at the same time
patients with a CPP close to CPPopt had the least per-
centage of favorable outcomes. This directly contrasts
the above mentioned findings with respect to mortality.
These inconsistencies may be due to the small sample
size and the total lack of patients with a delta CPP
above +10 mmHg. Patient numbers in total and especially
in the above CPPopt group (n = 6) were too small to draw
any definitive conclusions. Furthermore, the variable ‘time
spent within the CPPopt’ range was not an independent
predictor for any of the outcome variables.
Our study has various important limitations. First,
sample size was still relatively small and the study
included a highly selected population of ICH patients.
As stated above, especially the results of the outcome
analyses comparing the different groups based on their
proximity to CPPopt did not render any statistically
significant results and have to be weighed critically. Only
speculative conclusions can be drawn so far. Furthermore,
the study was an explorative retrospective analysis of
prospectively monitored, non-consecutive patients. Sample
size was not predetermined. Second, the amount of avail-
able data differed greatly among different individuals,
possibly adding further bias. However, reassuringly, total
monitoring time was not correlated to outcomes, PRx
or time of impaired PRx. Third, CPPopt was calculated
retrospectively and the amount of time spent within the
CPPopt range was relatively small (11%, range 0 to 33%).
In addition, calculation of CPPopt based on the currently
used automated algorithm was on average only possible
during half of the monitoring time. This may be due to
the fact that not all CPP values were covered by each
patient, rendering identification of CPPopt impossible
since it possibly lay outside the recorded values. This
limits the generalizability of the association between the
difference of ‘real CPP minus optimal CPP’ and outcome
after ICH. However, as stated above, the same percentage
(55%) was found in one other retrospective trial using
continuous calculation of CPPopt in TBI patients. This
number certainly has to be improved by carefully evaluat-
ing the reasons for failure of determination of CPPopt
and possibilities to increase the numbers. This should
be done in a prospective trial. Only after this issue has been
addressed can the CPPopt concept be safely introduced
for further clinical use. We are aware that a prospectively
conducted study, trying to optimize cerebral perfusion
based on an improved CPPopt algorithm may render
entirely different results due to the availability of larger
amounts of data and broader CPP variations. Finally, as
a technical limitation, times during CSF drainage aswell as patients following surgery and specifically two
patients following hemicraniectomy have been included
in our analysis. While the NEUROVENT probe allows
reliable ICP measurement also during CSF drainage, it
is unclear whether this will affect the reliability of PRx
assessment. Calculation of PRx is based on the principle
of a closed system, with ICP being a surrogate for changes
in intracerebral blood volume. However, considering the
fact that we clearly found positive correlations between
MAP and ICP and hence positive PRx values, we argue
that the system still reacts during times of drainage. The
same holds true for the two patients following hemi-
craniectomy. A comparison of PRx values and CPPopt
calculation before and after surgery suggests no systematic
difference in these two patients (compare Additional file 1:
Table S1). If specific patients during CSF drainage would
entirely have to be excluded, this would drastically reduce
the applicability of PRx for continuous assessment of pres-
sure reactivity in collectives like ICH or SAH. A study on
this issue is thus far missing. However, there are data indi-
cating that in situations with high brain compliance, for ex-
ample, following surgery, the PRx may not be an ideal
parameter, suggesting a different index PAx as an alterna-
tive, especially in situations with lower ICP [17]. Further-
more, a non-invasive alternative for continuous
determination of cerebrovascular reactivity and CPPopt
may be the near-infrared spectroscopy based index THx.
The index has been evaluated in TBI patients [18]. How-
ever, the applicability of THx in the setting of high brain
compliance has not been addressed. Furthermore, the
correlation between the autoregulation indices varies
around 0.5 [18] and 0.6 [17], indicating that different
techniques may represent distinct aspects of cerebrovascu-
lar reactivity and autoregulation. So far, the PRx remains
the best studied parameter, especially with respect to calcu-
lation of CPPopt and probably would be the parameter of
choice in a prospective trial on CPPopt management.
Despite these important limitations, the study encourages
further research on autoregulation-based CPP management
in ICH. Moreover, our finding of impaired dynamic auto-
regulation following ICH is corroborated by two other
independent studies using the Doppler flow velocity-based
index Mx [3,9]; one of them also reports a relationship
between impaired autoregulation and worse functional
outcome [3]. Further indirect arguments in favor of
individualized thresholds have just been provided in a
recent study on ICP management in TBI patients [19].
Chestnut and colleagues have compared an ICP-based
treatment protocol to a protocol solely based on clinical
observations. The outcomes in both groups did not differ.
The authors stress that their findings do not argue against
the use of ICP monitoring in general but only argue against
the monitoring-based interventional algorithm of lowering
ICP >20 mmHg. They suggest that the lack of efficacy of
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universal threshold for intracranial pressure. Currently, a
protocol for a prospective multicenter trial comparing
standard CPP management versus autoregulation-based
CPP management is being designed.
Conclusions
Due to a lack of ICH specific data, current guidelines for
CPP management in ICH recommend taking the func-
tioning of cerebral autoregulation into account but are
entirely based on data from TBI patients. Here we could
show that cerebrovascular pressure reactivity is impaired in
almost 50% of patients with severe ICH and impairment of
pressure reactivity was related to poor functional outcome
at three months. The CPPopt concept seems applicable to
ICH patients: CPPopt could be determined in all but one
patient and during 57% of the monitoring time. The me-
dian CPPopt was 83 mmHg and, therefore, considerably
higher than the cutoff value of 70 mmHg recommended
in the current guidelines. So far, however, a significant
relationship between functional outcome and CPPopt
could not be demonstrated in ICH patients. This may be
due to sample size and the retrospective approach. Larger,
prospective trials are needed to assess the validity of the
CPPopt concept for severe ICH patients.
Key messages
 Cerebrovascular pressure autoregulation was
impaired in half of the patients treated for severe
ICH.
 Impairment of pressure reactivity is independently
associated with poor functional outcome at three
months.
 The CPPopt concept seems applicable in ICH:
CPPopt was determinable in 57% of the total
monitoring time.
 The median CPPopt was 83 mmHg and thereby
considerably higher than the guideline
recommended value of 70 mmHg.
 Mortality was lowest in the group of patients with a
CPP close to their individual CPPopt.
Additional file
Additional file 1: Table S1. Comparison of PRx values and CPPopt
assessment before and after surgery for the two patients who had
hemicraniectomy.
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